Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-16-017195
Filing Date
2016-04-29
Accepted
2016-04-29 16:41:45
Documents
4
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A alxa-10ka_20151231.htm 10-K/A 1429294
2 EX-31.1 alxa-ex311_10.htm EX-31.1 8369
3 EX-31.2 alxa-ex312_9.htm EX-31.2 8485
4 EX-32.1 alxa-ex321_8.htm EX-32.1 5340
  Complete submission text file 0001564590-16-017195.txt   1452479
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

EIN.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-51820 | Film No.: 161607413
SIC: 2834 Pharmaceutical Preparations